Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

SKU ID : QYR-19325829 | Publishing Date : 13-Oct-2021 | No. of pages : 129

Detailed TOC of Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Exosomes and RNA
        1.2.3 CTCs and ctDNA
    1.3 Market by Application
        1.3.1 Global Lung Cancer Liquid Biops Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals and Clinics
        1.3.3 Physicians'Office Laboratories
        1.3.4 Clinical Diagnostic Laboratories
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Lung Cancer Liquid Biops Market Perspective (2016-2027)
    2.2 Lung Cancer Liquid Biops Growth Trends by Regions
        2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2016-2021)
        2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027)
    2.3 Lung Cancer Liquid Biops Industry Dynamic
        2.3.1 Lung Cancer Liquid Biops Market Trends
        2.3.2 Lung Cancer Liquid Biops Market Drivers
        2.3.3 Lung Cancer Liquid Biops Market Challenges
        2.3.4 Lung Cancer Liquid Biops Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Lung Cancer Liquid Biops Players by Revenue
        3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2016-2021)
        3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2016-2021)
    3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
    3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio
        3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2020
    3.5 Lung Cancer Liquid Biops Key Players Head office and Area Served
    3.6 Key Players Lung Cancer Liquid Biops Product Solution and Service
    3.7 Date of Enter into Lung Cancer Liquid Biops Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biops Breakdown Data by Type
    4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2016-2021)
    4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Liquid Biops Breakdown Data by Application
    5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2016-2021)
    5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Lung Cancer Liquid Biops Market Size (2016-2027)
    6.2 North America Lung Cancer Liquid Biops Market Size by Type
        6.2.1 North America Lung Cancer Liquid Biops Market Size by Type (2016-2021)
        6.2.2 North America Lung Cancer Liquid Biops Market Size by Type (2022-2027)
        6.2.3 North America Lung Cancer Liquid Biops Market Size by Type (2016-2027)
    6.3 North America Lung Cancer Liquid Biops Market Size by Application
        6.3.1 North America Lung Cancer Liquid Biops Market Size by Application (2016-2021)
        6.3.2 North America Lung Cancer Liquid Biops Market Size by Application (2022-2027)
        6.3.3 North America Lung Cancer Liquid Biops Market Size by Application (2016-2027)
    6.4 North America Lung Cancer Liquid Biops Market Size by Country
        6.4.1 North America Lung Cancer Liquid Biops Market Size by Country (2016-2021)
        6.4.2 North America Lung Cancer Liquid Biops Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Lung Cancer Liquid Biops Market Size (2016-2027)
    7.2 Europe Lung Cancer Liquid Biops Market Size by Type
        7.2.1 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021)
        7.2.2 Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027)
        7.2.3 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2027)
    7.3 Europe Lung Cancer Liquid Biops Market Size by Application
        7.3.1 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021)
        7.3.2 Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027)
        7.3.3 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2027)
    7.4 Europe Lung Cancer Liquid Biops Market Size by Country
        7.4.1 Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021)
        7.4.2 Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size (2016-2027)
    8.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type
        8.2.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2027)
    8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application
        8.3.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2027)
    8.4 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region
        8.4.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Lung Cancer Liquid Biops Market Size (2016-2027)
    9.2 Latin America Lung Cancer Liquid Biops Market Size by Type
        9.2.1 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021)
        9.2.2 Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027)
        9.2.3 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2027)
    9.3 Latin America Lung Cancer Liquid Biops Market Size by Application
        9.3.1 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021)
        9.3.2 Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027)
        9.3.3 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2027)
    9.4 Latin America Lung Cancer Liquid Biops Market Size by Country
        9.4.1 Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021)
        9.4.2 Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size (2016-2027)
    10.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type
        10.2.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2027)
    10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application
        10.3.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2027)
    10.4 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country
        10.4.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Biocept
        11.1.1 Biocept Company Details
        11.1.2 Biocept Business Overview
        11.1.3 Biocept Lung Cancer Liquid Biops Introduction
        11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.1.5 Biocept Recent Development
    11.2 EntroGen
        11.2.1 EntroGen Company Details
        11.2.2 EntroGen Business Overview
        11.2.3 EntroGen Lung Cancer Liquid Biops Introduction
        11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.2.5 EntroGen Recent Development
    11.3 Cynvenio Biosystems
        11.3.1 Cynvenio Biosystems Company Details
        11.3.2 Cynvenio Biosystems Business Overview
        11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
        11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.3.5 Cynvenio Biosystems Recent Development
    11.4 Exosome Diagnostics
        11.4.1 Exosome Diagnostics Company Details
        11.4.2 Exosome Diagnostics Business Overview
        11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
        11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.4.5 Exosome Diagnostics Recent Development
    11.5 F. Hoffmann-La Roche
        11.5.1 F. Hoffmann-La Roche Company Details
        11.5.2 F. Hoffmann-La Roche Business Overview
        11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
        11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.5.5 F. Hoffmann-La Roche Recent Development
    11.6 Clearbridge BioMedics
        11.6.1 Clearbridge BioMedics Company Details
        11.6.2 Clearbridge BioMedics Business Overview
        11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
        11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.6.5 Clearbridge BioMedics Recent Development
    11.7 Bio-Rad Laboratories
        11.7.1 Bio-Rad Laboratories Company Details
        11.7.2 Bio-Rad Laboratories Business Overview
        11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
        11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.7.5 Bio-Rad Laboratories Recent Development
    11.8 Agena Bioscience
        11.8.1 Agena Bioscience Company Details
        11.8.2 Agena Bioscience Business Overview
        11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
        11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.8.5 Agena Bioscience Recent Development
    11.9 Cancer Genetics
        11.9.1 Cancer Genetics Company Details
        11.9.2 Cancer Genetics Business Overview
        11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
        11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.9.5 Cancer Genetics Recent Development
    11.10 CellMax Life
        11.10.1 CellMax Life Company Details
        11.10.2 CellMax Life Business Overview
        11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
        11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.10.5 CellMax Life Recent Development
    11.11 Nateras
        11.11.1 Nateras Company Details
        11.11.2 Nateras Business Overview
        11.11.3 Nateras Lung Cancer Liquid Biops Introduction
        11.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.11.5 Nateras Recent Development
    11.12 MedGenome
        11.12.1 MedGenome Company Details
        11.12.2 MedGenome Business Overview
        11.12.3 MedGenome Lung Cancer Liquid Biops Introduction
        11.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.12.5 MedGenome Recent Development
    11.13 OncoDNA
        11.13.1 OncoDNA Company Details
        11.13.2 OncoDNA Business Overview
        11.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
        11.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.13.5 OncoDNA Recent Development
    11.14 Genomic Health
        11.14.1 Genomic Health Company Details
        11.14.2 Genomic Health Business Overview
        11.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
        11.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.14.5 Genomic Health Recent Development
    11.15 Trovagene
        11.15.1 Trovagene Company Details
        11.15.2 Trovagene Business Overview
        11.15.3 Trovagene Lung Cancer Liquid Biops Introduction
        11.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.15.5 Trovagene Recent Development
    11.16 Fluxion Biosciences
        11.16.1 Fluxion Biosciences Company Details
        11.16.2 Fluxion Biosciences Business Overview
        11.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
        11.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.16.5 Fluxion Biosciences Recent Development
    11.17 Biodesix
        11.17.1 Biodesix Company Details
        11.17.2 Biodesix Business Overview
        11.17.3 Biodesix Lung Cancer Liquid Biops Introduction
        11.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.17.5 Biodesix Recent Development
    11.18 Epic Sciences
        11.18.1 Epic Sciences Company Details
        11.18.2 Epic Sciences Business Overview
        11.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
        11.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.18.5 Epic Sciences Recent Development
    11.18 Shuwen Biotech
        .1 Shuwen Biotech Company Details
        .2 Shuwen Biotech Business Overview
        .3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
        .4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        .5 Shuwen Biotech Recent Development
    11.20 Personal Genome Diagnostics
        11.20.1 Personal Genome Diagnostics Company Details
        11.20.2 Personal Genome Diagnostics Business Overview
        11.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
        11.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.20.5 Personal Genome Diagnostics Recent Development
    11.21 Predicine
        11.21.1 Predicine Company Details
        11.21.2 Predicine Business Overview
        11.21.3 Predicine Lung Cancer Liquid Biops Introduction
        11.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021)
        11.21.5 Predicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Exosomes and RNA
    Table 3. Key Players of CTCs and ctDNA
    Table 4. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Lung Cancer Liquid Biops Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Lung Cancer Liquid Biops Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Lung Cancer Liquid Biops Market Share by Regions (2016-2021)
    Table 8. Global Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027)
    Table 10. Lung Cancer Liquid Biops Market Trends
    Table 11. Lung Cancer Liquid Biops Market Drivers
    Table 12. Lung Cancer Liquid Biops Market Challenges
    Table 13. Lung Cancer Liquid Biops Market Restraints
    Table 14. Global Lung Cancer Liquid Biops Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Lung Cancer Liquid Biops Market Share by Players (2016-2021)
    Table 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020)
    Table 17. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biops Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Lung Cancer Liquid Biops Product Solution and Service
    Table 21. Date of Enter into Lung Cancer Liquid Biops Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021)
    Table 25. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Lung Cancer Liquid Biops Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2016-2021)
    Table 29. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Biocept Company Details
    Table 62. Biocept Business Overview
    Table 63. Biocept Lung Cancer Liquid Biops Product
    Table 64. Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 65. Biocept Recent Development
    Table 66. EntroGen Company Details
    Table 67. EntroGen Business Overview
    Table 68. EntroGen Lung Cancer Liquid Biops Product
    Table 69. EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 70. EntroGen Recent Development
    Table 71. Cynvenio Biosystems Company Details
    Table 72. Cynvenio Biosystems Business Overview
    Table 73. Cynvenio Biosystems Lung Cancer Liquid Biops Product
    Table 74. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 75. Cynvenio Biosystems Recent Development
    Table 76. Exosome Diagnostics Company Details
    Table 77. Exosome Diagnostics Business Overview
    Table 78. Exosome Diagnostics Lung Cancer Liquid Biops Product
    Table 79. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 80. Exosome Diagnostics Recent Development
    Table 81. F. Hoffmann-La Roche Company Details
    Table 82. F. Hoffmann-La Roche Business Overview
    Table 83. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product
    Table 84. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 85. F. Hoffmann-La Roche Recent Development
    Table 86. Clearbridge BioMedics Company Details
    Table 87. Clearbridge BioMedics Business Overview
    Table 88. Clearbridge BioMedics Lung Cancer Liquid Biops Product
    Table 89. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 90. Clearbridge BioMedics Recent Development
    Table 91. Bio-Rad Laboratories Company Details
    Table 92. Bio-Rad Laboratories Business Overview
    Table 93. Bio-Rad Laboratories Lung Cancer Liquid Biops Product
    Table 94. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 95. Bio-Rad Laboratories Recent Development
    Table 96. Agena Bioscience Company Details
    Table 97. Agena Bioscience Business Overview
    Table 98. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 99. Agena Bioscience Recent Development
    Table 100. Cancer Genetics Company Details
    Table 101. Cancer Genetics Business Overview
    Table 102. Cancer Genetics Lung Cancer Liquid Biops Product
    Table 103. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 104. Cancer Genetics Recent Development
    Table 105. CellMax Life Company Details
    Table 106. CellMax Life Business Overview
    Table 107. CellMax Life Lung Cancer Liquid Biops Product
    Table 108. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 109. CellMax Life Recent Development
    Table 110. Nateras Company Details
    Table 111. Nateras Business Overview
    Table 112. Nateras Lung Cancer Liquid Biops Product
    Table 113. Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 114. Nateras Recent Development
    Table 115. MedGenome Company Details
    Table 116. MedGenome Business Overview
    Table 117. MedGenome Lung Cancer Liquid Biops Product
    Table 118. MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 119. MedGenome Recent Development
    Table 120. OncoDNA Company Details
    Table 121. OncoDNA Business Overview
    Table 122. OncoDNA Lung Cancer Liquid Biops Product
    Table 123. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 124. OncoDNA Recent Development
    Table 125. Genomic Health Company Details
    Table 126. Genomic Health Business Overview
    Table 127. Genomic Health Lung Cancer Liquid Biops Product
    Table 128. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 129. Genomic Health Recent Development
    Table 130. Trovagene Company Details
    Table 131. Trovagene Business Overview
    Table 132. Trovagene Lung Cancer Liquid Biops Product
    Table 133. Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 134. Trovagene Recent Development
    Table 135. Fluxion Biosciences Company Details
    Table 136. Fluxion Biosciences Business Overview
    Table 137. Fluxion Biosciences Lung Cancer Liquid Biops Product
    Table 138. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 139. Fluxion Biosciences Recent Development
    Table 140. Biodesix Company Details
    Table 141. Biodesix Business Overview
    Table 142. Biodesix Lung Cancer Liquid Biops Product
    Table 143. Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 144. Biodesix Recent Development
    Table 145. Epic Sciences Company Details
    Table 146. Epic Sciences Business Overview
    Table 147. Epic Sciences Lung Cancer Liquid Biops Product
    Table 148. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 149. Epic Sciences Recent Development
    Table 150. Shuwen Biotech Company Details
    Table 151. Shuwen Biotech Business Overview
    Table 152. Shuwen Biotech Lung Cancer Liquid Biops Product
    Table 153. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 154. Shuwen Biotech Recent Development
    Table 155. Personal Genome Diagnostics Company Details
    Table 156. Personal Genome Diagnostics Business Overview
    Table 157. Personal Genome Diagnostics Lung Cancer Liquid Biops Product
    Table 158. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 159. Personal Genome Diagnostics Recent Development
    Table 160. Predicine Company Details
    Table 161. Predicine Business Overview
    Table 162. Predicine Lung Cancer Liquid Biops Product
    Table 163. Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
    Table 164. Predicine Recent Development
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biops Market Share by Type: 2020 VS 2027
    Figure 2. Exosomes and RNA Features
    Figure 3. CTCs and ctDNA Features
    Figure 4. Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals and Clinics Case Studies
    Figure 6. Physicians'Office Laboratories Case Studies
    Figure 7. Clinical Diagnostic Laboratories Case Studies
    Figure 8. Lung Cancer Liquid Biops Report Years Considered
    Figure 9. Global Lung Cancer Liquid Biops Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Lung Cancer Liquid Biops Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Lung Cancer Liquid Biops Market Share by Regions: 2020 VS 2027
    Figure 12. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027)
    Figure 13. Global Lung Cancer Liquid Biops Market Share by Players in 2020
    Figure 14. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2020
    Figure 16. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021)
    Figure 17. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027)
    Figure 18. North America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Lung Cancer Liquid Biops Market Share by Type (2016-2027)
    Figure 20. North America Lung Cancer Liquid Biops Market Share by Application (2016-2027)
    Figure 21. North America Lung Cancer Liquid Biops Market Share by Country (2016-2027)
    Figure 22. United States Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Lung Cancer Liquid Biops Market Share by Type (2016-2027)
    Figure 26. Europe Lung Cancer Liquid Biops Market Share by Application (2016-2027)
    Figure 27. Europe Lung Cancer Liquid Biops Market Share by Country (2016-2027)
    Figure 28. Germany Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Lung Cancer Liquid Biops Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Lung Cancer Liquid Biops Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2016-2027)
    Figure 38. China Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Lung Cancer Liquid Biops Market Share by Type (2016-2027)
    Figure 46. Latin America Lung Cancer Liquid Biops Market Share by Application (2016-2027)
    Figure 47. Latin America Lung Cancer Liquid Biops Market Share by Country (2016-2027)
    Figure 48. Mexico Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Lung Cancer Liquid Biops Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Lung Cancer Liquid Biops Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2016-2027)
    Figure 54. Turkey Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 58. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 59. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 60. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 62. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 64. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 65. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 66. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 67. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 68. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 69. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 70. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 71. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 72. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 73. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 74. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 75. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 76. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 77. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Keyplayers in Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine

Request Sample

Pre-order Enquiry

Request Discount

Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

Detailed TOC of Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

List of Figures, Tables and Charts Available in Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

Keyplayers in Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2021-2027

Our Clients